---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-027194"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T09:17:15.429427+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# agilon health Q2 revenue $1.15B (+71%); posts first positive Adj EBITDA $10M; updates FY2023 guidance

## Summary
- Revenue $1.15B, +71% YoY; Medicare Advantage members 408,900 (+57%); total members live on platform 495,900.
- Adjusted EBITDA $10M vs -$3M YoY; net loss $17M vs $21M YoY; medical margin $138M (+69%).
- FY2023 guidance: revenue $4.525-4.540B (up); medical margin $500-530M (down); Adj EBITDA $0-23M.
- ACO REACH contribution to Adj EBITDA raised to $30-35M for FY2023 from prior $5-10M.
- Announced partnership with Center for Primary Care (8 locations in GA/SC); share repurchase of 9.6M shares for ~$200M.

## SEC filing metadata
- accession: 0001628280-23-027194
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/agl-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-027194
- JSON: https://secwatch.observer/filing/0001628280-23-027194.json
- Plain text: https://secwatch.observer/filing/0001628280-23-027194.txt

## Key facts
- Earnings Releases
  agilon health, inc. updated its fiscal year 2023 guidance (reaffirmed).
  - Period: fiscal year 2023
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Outlook for Fiscal Year 2023: Year Ended December 31, 2023 Updated Guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm
- Earnings Releases
  agilon health, inc. reported the three and six months ended June 30, 2023 results: revenue $1.15 billion, net income Net loss of $17 million.
  - Period: the three and six months ended June 30, 2023
  - Revenue: $1.15 billion
  - Net income: Net loss of $17 million
  - Result: reported results
  source text: agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm
- Earnings Releases
  agilon health, inc. reported the second quarter ended June 30, 2023 results: revenue $1.15 billion, net income Net loss of $17 million. Guidance reaffirmed.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $1.15 billion
  - Net income: Net loss of $17 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: except as shall be expressly set forth by specific reference therein. --- EX-99.1 (EX-99.1) --- agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900 Durability of agilon partnership model driving continued
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.